IntrinsiQ Acquires Market Research Firm WWMR
The News Review:
- IntrinsiQ Acquires Market Research Firm WWMR
- Directory of Clinical Research Companies in India …
- NJ-based research powering global drug development
IntrinsiQ Acquires Market Research Firm WWMR
SYS-CN Media (press release)
For the first time primary research panels can be quickly assembled and tightly aligned with IntrinsiQ?s real-time database of more than 600 oncologists nationwide and their practice behavior. Founded 15 years ago WWMR brings deep expertise in oncology research having established and served as the secondary market research arm of Genentech for the past decade. The boutique firm specializes in qualitative and quantitative market research product and market assessments forecasts and economic analysis conducted through every stage of the clinical research and drug development process. ?As oncology treatment becomes more complex and more specialized the stakes get raised on pharmaceutical teams? sizeable R&D investment? said Mike Raquet general manager of IntrinsiQ?s pharmaceutical information division. ?WWMR brings deep understanding and immediate access to doctors on the front lines ? the best way for pharmaceutical companies to affirm strategic directions sooner and with greater assurances for RI. ? Twenty-seven of the top 30 pharmaceutical oncology organizations rely on IntrinsiQ?s unmatched database of 2 million drug administrations given annually collected from oncology practices nationwide using IntrinsiQ?s flagship clinical oncology software IntelliDose®. ?This alignment is a perfect marriage because of our organizations? shared mission of improving the quality and understanding of cancer care? said Susan lsen WWMR founder and president who becomes vice president consulting services in IntrinsiQ?s pharmaceutical information division.
Directory of Clinical Research Companies in India …
PR-Inside.com (Pressemitteilung)
India also has the advantage of having a large pool of highly trained physicians nurses and technical personnel; numerous world-class medical facilities; broadly developed information technology infrastructure; a favourable IPR environment (post signing the WT agreement) and use of English as the primary business and medical language. The total value of clinical research performed in India in 2007 is estimated about US$200 million. The major companies involved in Clinical research in India have a wide range of services to offer. Thus the industry needs to know the companies operating in this field. The directory of ‘Clinical Research Companies in India’ is the answer to it and has been prepared as a ready-reckoner for use by the industry globally pharma and biotech companies contract research companies funding organisations and others. It has been compiled considering the companies involved in clinical research and support services.
NJ-based research powering global drug development
NJBIZ
New Jersey also offers the ideal location for Daiichi Sankyo’s business model which “incorporates outsourcing as a strategic component” Gormley said. The company believes in leveraging “a small core” of people with outsourced partners he said. ne of Daiichi Sankyo’s biggest outsourced partners in the state is MDS Pharmaceuticals a clinical research organization in Neptune. Daiichi has leased 30 beds with dedicated staff at the facility where it conducts trials; it recently marked its 100th study at MDS over eight years Alexander said. A growing number of industries including Big Pharma are increasingly restructuring their R&D organizations “to split it out somehow and try and act smaller” Alexander said as the old model of centralizing R&D operations in-house has failed. “If R&D is scalable then whoever spends the most money should have the most success in drug discovery right?” he said. “That hasn’t really worked out.
Related from Transitions-for-women: Cyntellect Appoints Former GE Healthcare Director Gareth Jones as …
Written by admin on June 9th, 2009 with
no comments.
Read more articles on News.